Trial
NCT04049383
CAR-20/19-T Cells in Patients With Relapsed/Refractory B Cell ALL
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Medical College of Wisconsin
Collaborators
Children's Hospital and Health System Foundation, Wisconsin
Condition
Acute Lymphoblastic Leukemia, in Relapse
Intervention
CAR-20/19-T cells (5 x 10^5 CAR-20/19-T cells/kg)
Why stopped
Low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-12